October 19, 2015

A recent study explored the best route for transplanting stem cells derived from cord tissue to protect against neonatal hyperoxic lung injury. To achieve this goal, researchers performed gene expression profiling to compare the effects of two forms of cord blood cell administration: intratracheal (IT) vs. intravenous (IV).

This study was performed in lab rats, but used human cells, which can be collected by family cord blood and tissue services. The end results showed that local IT transplantation was more effective than systemic IV administration in protecting against hyperoxic lung injury.

Perhaps you have been wondering, “Why save baby cord blood?” One of the reasons why we believe every family should do so is because of the wide range of diseases cord blood stem cells have been able to treat effectively. Family cord blood banking services report that it can currently be used to treat more than 80 diseases. That’s great news, and it’s even better to know that research is ongoing, meaning that more treatments and potential cures are continually being pursued. If there is a history of disease in your family, storing your child’s cells is a wise choice. Even if cord blood cannot treat that disease today, there is a possibility that it could in the future.

Not only are researchers looking for new diseases that can be treated using cord blood and tissue, they are also looking for new transplant methods, as described in one of the cases above. In time, this will make treatments using cells from family cord blood services even safer and more effective than they are now.

It should be noted that the stem cells used in this particular study were derived from umbilical cord tissue. Though it is not currently approved for treatments in humans at this time, researchers are performing studies like these to determine viable cord tissue benefits for the future.

FaceBook  Twitter